HLB Genex, Inc. (KOSDAQ:187420)

South Korea · Delayed Price · Currency is KRW

2,650.00

-35.00 (-1.30%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
New Drug Development	9.35M	1.51B	-	-	-
New Drug Development Growth	-99.38%	-	-	-	-
Enzyme/Material Business	35.42B	25.50B	27.80B	25.87B	18.77B
Enzyme/Material Business Growth	38.90%	-8.28%	7.45%	37.85%	25.62%
Total	35.43B	27.01B	27.80B	25.87B	18.77B
Total Growth	31.18%	-2.85%	7.45%	37.85%	25.62%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	23.62B	18.36B	17.04B	18.40B	12.97B
South Korea Growth	28.64%	7.71%	-7.35%	41.80%	24.12%
China	-	-	-	-	1.79B
China Growth	-	-	-	-	411.38%
Netherlands	4.55B	2.63B	4.61B	1.34B	-
Netherlands Growth	73.27%	-42.99%	244.20%	-	-
USA	2.29B	1.54B	1.78B	1.98B	1.70B
USA Growth	48.71%	-13.24%	-10.05%	16.30%	-10.98%
UK	738.00M	1.96B	1.44B	1.51B	-
UK Growth	-62.29%	35.60%	-4.68%	-	-
Other	1.85B	1.72B	2.93B	2.65B	2.31B
Other Growth	7.91%	-41.45%	10.61%	14.73%	3.51%
Thailand	2.38B	809.55M	-	-	-
Thailand Growth	194.21%	-	-	-	-
Total	35.43B	27.01B	27.80B	25.87B	18.77B
Total Growth	31.18%	-2.85%	7.45%	37.85%	25.62%

Source: S&P Global Market Intelligence.